首页> 外文期刊>Asian Journal of Medical Sciences >Protective assessment of cimetidine against cyclophosphamide-induced kidney injury
【24h】

Protective assessment of cimetidine against cyclophosphamide-induced kidney injury

机译:西咪替丁对环磷酰胺引起的肾脏损伤的保护性评估

获取原文
       

摘要

Background: Nephrotoxicity is one of the frequent toxicities observed with cyclophosphamide (CP) use which may involve oxidative stress. Cimetidine is an antihistamine with anti-oxidative stress activity. Aims and Objectives: The study aimed to evaluate the effect of cimetidine on cyclophosphamide-induced kidney damage in albino rats. Materials and Methods: Forty eight adult rats randomised into 8 (A-H) groups of 6 rats per group were experimentally used for this study.Group A (control) was treated with water, while groups B-D were treated with 5, 10 and 20 mg/kg of cimetidine intraperitoneally (ip) daily for 5 days respectively. Group E was treated with150 mg/kgof CP ip on the 5th day. Groups F-H were pretreated with 5, 10 and 20 mg/kg cimetidine ip daily for 5 days and treated with CP ip on the 5th day respectively. Rats were sacrificed serum was extracted from blood and evaluated for renal function markers, while kidneys were harvested and evaluated for oxidative stress markers and histology. Results: There were no significant effects (p>0.05) on the body and kidney weights of CP-treated rats. However, impaired kidney functions in CP-treated rats were marked by significant (p<0.05) increases in creatinine, urea, uric acid, sodium, potassium, chloride, bicarbonate, and malondialdehyde levels when compared to control. On the other hand, significant (p<0.05) decreases in superoxide dismutase, catalase, glutathione, glutathione peroxidase, total protein and albumin were obtained in CP-treated rats when compared to control. Necrotic changes were observed in the kidneys of CP-treated rats. However, CP-induced nephrotoxic effects were significantly (p<0.05; 0.01) reversed in cimetidine pretreated rats. Conclusion: Cimetidine shows potential as adjunct remedy for cyclophosphamide associated nephrotoxicity. Asian Journal of Medical Sciences Vol.9(6) 2018 25-30.
机译:背景:肾毒性是使用环磷酰胺(CP)观察到的常见毒性之一,可能涉及氧化应激。西咪替丁是具有抗氧化应激活性的抗组胺药。目的和目的:该研究旨在评估西咪替丁对环磷酰胺引起的白化病大鼠肾脏损害的作用。材料与方法:将48只成年大鼠随机分为8组(AH),每组6只大鼠,A组(对照组)用水处理,而BD组分别以5、10和20 mg /每天腹膜内(ip)公斤西咪替丁5天内。 E组在第5天用150 mg / kg的CP ip ip治疗。 F-H组每天分别以5、10和20 mg / kg西咪替丁ip腹腔内预处理5天,并分别在第5天以CP ip预处理。处死大鼠,从血液中提取血清并评估其肾功能标志物,同时收集肾脏并评估其氧化应激标志物和组织学。结果:对CP治疗的大鼠的身体和肾脏重量没有显着影响(p> 0.05)。但是,与对照组相比,CP治疗大鼠的肾功能受损的特点是肌酐,尿素,尿酸,钠,钾,氯,碳酸氢盐和丙二醛水平显着(p <0.05)增加。另一方面,与对照组相比,在CP处理的大鼠中获得了超氧化物歧化酶,过氧化氢酶,谷胱甘肽,谷胱甘肽过氧化物酶,总蛋白和白蛋白的显着(p <0.05)降低。在CP治疗的大鼠的肾脏中观察到了坏死变化。然而,在西咪替丁预处理的大鼠中,CP诱导的肾毒性作用显着(p <0.05; 0.01)逆转。结论:西咪替丁具有作为环磷酰胺相关肾毒性的辅助疗法的潜力。亚洲医学杂志Vol.9(6)2018 25-30。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号